美股异动丨辉瑞(PFE)跌超5%Q2营收不及预期遭多家大行下调目标评级
格隆汇7月30日丨辉瑞(PFE)今日股价再度下跌,现跌5.65%,报39.11美元,暂成交6.31亿美元,最新总市值为2292.67亿美元。辉瑞二季度财报显示,营收为132.64亿美元,同比下降2%,低于市场预期;归属于股东净利润为50.46亿美元,同比增长30%。辉瑞预计2019财年全年营收由之前的520-540亿美元下调至505-525亿美元,全年调整后每股收益由之前的2.83-2.93美元下调至2.76-2.86美元。同时,辉瑞和Mylan宣布达成最终协议,将Mylan与辉瑞公司的非专利品牌和仿制药部门普强(Upjohn)合并,创建一家新的全球制药公司。摩根大通将辉瑞评级下调至与大市持平;美银美林将评级下调至中性,目标价41美元;摩根士丹利将评级从增持降至与大市持平,目标价从48美元降至40美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.